Developmental/Behavioral Disorders

Adolescents from socioeconomically deprived families reported more eating disorder symptoms, highlighting disparities in risk and diagnosis.

Pediatricians empower families of children with disabilities by promoting ABLE accounts, enhancing financial security and access to essential resources.

Frequent exposure to cannabis and e-cigarette posts on social media is linked to increased teen cannabis and dual substance use, according to a study published in JAMA.

AAP updates clinical guidance to help pediatricians navigate genetic evaluation of children with global developmental delay or intellectual disability.

New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.

CBD cannabis extract may improve social responsiveness and reduce disruptive behavior in children with autism, with no increase in adverse effects, according to a recent study

Parents’ screen habits influence kids' media use, with bedroom and mealtime screen time increasing exposure to mature content.

"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.

Findings support continued caution in the use of glucocorticoids among pregnant people.

A study presented at the American Academy of Pediatrics 2024 National Conference finds children with disabilities in foster care face lower permanency rates and higher mortality risks, calling for specialized support and interventions.

Investigators concluded that findings suggest the need for improved public health messaging regarding fish intake guidelines for pregnant persons.

A recent study finds kangaroo care boosts brain development in premature infants, showing even brief skin-to-skin contact leads to better cognitive outcomes at 1 year.

How can tablet use contribute to expressions of anger and frustration among children aged 3.5 to 5.5 years?

Many preterm infants are considered to be “caught up” to their peers during the toddler years, but evidence is mounting that even late preterm infants may experience ongoing academic and developmental delays.

ConSynance Therapeutics' CSTI-500, an innovative Triple Monoamine Reuptake Inhibitor, has received FDA's Rare Pediatric Disease Designation for treating Prader-Willi Syndrome in children.

From baseline to final assessment, all 7 matched cerliponase alfa-treated children under 3 years of age maintained a motor score of 3, representing a "grossly normal gait, signifying a delay in disease onset," stated BioMarin.

A laboratory-based assessment shows children aged 18 - 32 months old were less likely to listen to attention prompts or their parent's requests when provided an iPad versus a standard toy.

Investigators therefore concluded that ROAR provides an excellent way to identify children at highest risk of having poor reading skills.

Overall, the findings of the study support the clinical utility of combining trio-WES sequencing with CNV-seq in the etiologic diagnosis and management of early-childhood GDD.

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics and how these articles can be utilized in the everyday practice of PNPs.

Investigators aimed to assess effectiveness of early and continuous enrichment intervention on motor, cognitive, and functional skills in infants with CP.

Study in JAMA: Antenatal corticosteroids don't impact neurodevelopment in late preterm children aged 6 years and up.

An assessment into development scores before, during and after the COVID-19 pandemic show children aged 0 - 5 years old may only had been minimally impacted in communication and problem-solving skills.

A recently published study in JAMA sought to determine if there is a link between acetaminophen use during pregnancy and children’s risk of developing autism, ADHD, or intellectual disabilities.

HCPs can provide resources to help parents make an informed decision.